BNP PARIBAS ASSET MANAGEMENT Holding S.A. Grows Stake in Revvity Inc. $RVTY

Key Points

• BNP PARIBAS ASSET MANAGEMENT Holding S.A. significantly increased its stake in Revvity Inc. by 655.7%, owning approximately 95,138 shares worth about $10.07 million at the end of the last quarter.
• Several hedge funds have shown positive interest in Revvity, with T. Rowe Price Investment Management increasing its position by 16.7% and Vanguard Group lifting its stake by 0.6% in the first quarter.
• Analysts have mixed opinions with the average rating for Revvity at "Moderate Buy" and a current average price target of $120.07, despite some recent downgrades and price target reductions from various firms.

BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its position in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 655.7% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 95,138 shares of the company's stock after buying an additional 82,548 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. owned approximately 0.08% of Revvity worth $10,065,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Optiver Holding B.V. bought a new position in Revvity during the fourth quarter valued at approximately $33,000. Quarry LP boosted its stake in Revvity by 45.7% during the fourth quarter. Quarry LP now owns 303 shares of the company's stock valued at $34,000 after buying an additional 95 shares during the last quarter. Vermillion Wealth Management Inc. bought a new position in Revvity during the fourth quarter valued at approximately $41,000. New Age Alpha Advisors LLC bought a new position in Revvity during the first quarter valued at approximately $44,000. Finally, Continuum Advisory LLC boosted its stake in Revvity by 39.3% during the fourth quarter. Continuum Advisory LLC now owns 471 shares of the company's stock valued at $53,000 after buying an additional 133 shares during the last quarter. 86.65% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Stifel Nicolaus dropped their price target on Revvity from $120.00 to $110.00 and set a "hold" rating for the company in a research note on Tuesday, July 29th. Bank of America decreased their price objective on Revvity from $116.00 to $110.00 and set a "buy" rating on the stock in a research report on Thursday, June 26th. UBS Group upgraded Revvity from a "neutral" rating to a "buy" rating and decreased their price objective for the company from $145.00 to $115.00 in a research report on Thursday, May 1st. Evercore ISI decreased their price objective on Revvity from $116.00 to $115.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. Finally, Robert W. Baird decreased their price objective on Revvity from $127.00 to $125.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 29th. Ten equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $120.07.

Revvity Trading Up 0.3%

Shares of RVTY stock traded up $0.2870 on Wednesday, reaching $91.7070. 1,127,816 shares of the company's stock were exchanged, compared to its average volume of 1,529,810. Revvity Inc. has a 52 week low of $85.12 and a 52 week high of $129.50. The company has a current ratio of 3.33, a quick ratio of 2.75 and a debt-to-equity ratio of 0.43. The stock has a market capitalization of $10.64 billion, a PE ratio of 38.86, a P/E/G ratio of 2.45 and a beta of 0.91. The company's fifty day simple moving average is $94.69 and its 200 day simple moving average is $99.49.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings results on Monday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.14 by $0.04. Revvity had a return on equity of 7.66% and a net margin of 10.19%.The firm had revenue of $720.28 million during the quarter, compared to analyst estimates of $711.26 million. During the same period last year, the company earned $1.22 EPS. Revvity's quarterly revenue was up 4.1% compared to the same quarter last year. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. As a group, analysts forecast that Revvity Inc. will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 7th. Investors of record on Friday, October 17th will be paid a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Friday, October 17th. Revvity's dividend payout ratio (DPR) is currently 11.86%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.